Vaccination against infectious diseases: What is promising?
- 27 July 2014
- journal article
- review article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 203 (6) , 365-371
Abstract
Vaccination has proven to be one of the best weapons protecting the mankind against infectious diseases. Along with the huge progress in microbiology, numerous highly efficacious and safe vaccines have been produced by conventional technology (cultivation), by the use of molecular biology (genetic modification), or by synthetic chemistry. Sterilising prevention is achieved by the stimulation of antibody production, while the stimulation of cell-mediated immune responses may prevent the outbreak of disease in consequence of an acute or reactivated infection. From several examples, two rules are deduced to evaluate the perspectives of future vaccine developments: They are promising, if (1) the natural infectious disease induces immunity or (2) passive immunisation (transfer of antibodies, adoptive transfer of lymphocytes) is successful in preventing infection.Keywords
This publication has 82 references indexed in Scilit:
- Inflammation in tuberculosis: interactions, imbalances and interventionsCurrent Opinion in Immunology, 2013
- Viral pathogen discoveryCurrent Opinion in Microbiology, 2013
- Tuberculosis vaccines: Time to think about the next generationSeminars in Immunology, 2013
- A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in HumansPLOS ONE, 2013
- Monitoring of Pathogen-Specific T-Cell Immune Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationFrontiers in Immunology, 2013
- Performance evaluation of a new fourth-generation HIV combination antigen–antibody assayMedical Microbiology and Immunology, 2012
- Poor immunity status against poliomyelitis in medical students: a semi-anonymous studyMedical Microbiology and Immunology, 2012
- Deficiency of immunity to poliovirus type 3: a lurking danger?BMC Infectious Diseases, 2012
- Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virusMedical Microbiology and Immunology, 2009
- Papillomaviruses in the causation of human cancers — a brief historical accountVirology, 2009